Search Results - Maria T. Bourlon
- Showing 1 - 18 results of 18
-
1
-
2
-
3
-
4
Differences in the expression of the phosphatase PTP-1B in patients with localized prostate cancer with and without adverse pathological features by Maria T. Bourlon, Maria T. Bourlon, Shaddai Urbina-Ramirez, Haydee C. Verduzco-Aguirre, Mauricio Mora-Pineda, Hugo E. Velazquez, Eucario Leon-Rodriguez, Yemil Atisha-Fregoso, María G. De Anda-Gonzalez
Published in Frontiers in Oncology (2024-04-01)Get full text
Article -
5
Intersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022 by Laure-Anne Teuwen, Joanna Young, Saleh Alessy, Berna C. Özdemir, Diah Martina, Sharif Folorunso, Maria T. Bourlon, Hans Prenen, Eva Segelov
Published in JCO Global Oncology (2024-10-01)Get full text
Article -
6
-
7
Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma by Ray Manneh Kopp, Fernando Galanternik, Fabio A. Schutz, Fabio Kater, Allan Ramos-Esquivel, Silvia Neciosup, Nora Sobrevilla-Moreno, Laura Bernal Vaca, Linda Ibatá-Bernal, Susan Martínez-Rojas, Maria T. Bourlon
Published in JCO Global Oncology (2024-01-01)Get full text
Article -
8
Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO by Maria T. Bourlon, Ami S. Bhatt, Gilberto Lopes, Fredrick Chite Asirwa, Alexandru E. Eniu, Patrick J. Loehrer, Lawrence N. Shulman, Julia Close, Jamie Von Roenn, Michal Tibbits, Doug Pyle, Julie R. Gralow
Published in JCO Global Oncology (2024-04-01)Get full text
Article -
9
Overview and characterization of penile cancer content across social media platforms by Ruben Alejandro Ortiz-Guerra, Salvador Jaime-Casas, Bertha Alejandra Martinez-Cannon, Jose C. Ariza-Avila, Ana P. González-Morales, Andrea Bardan-Duarte, Yuly A. Remolina-Bonilla, Philippe E. Spiess, Maria T. Bourlon
Published in Frontiers in Oncology (2023-12-01)Get full text
Article -
10
Treatment Patterns for Metastatic Urothelial Carcinoma Across Eight Mexican Centers: The ALEBRIJE Study by Evelyn Lilian Beas-Lozano, Yuly A. Remolina-Bonilla, Rosa Caballero, Nora Sobrevilla-Moreno, Perla Perez-Perez, Maria Guadalupe Díaz-Alvarado, Omar Alejandro Zayas-Villanueva, Erika Adriana Martinez-Castañeda, Saul Campos-Gomez, Luis Arturo Cardoso-Aparicio, Dolores Mendoza-Oliva, Maria T. Bourlon
Published in JCO Global Oncology (2025-04-01)Get full text
Article -
11
Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study by Maria T. Bourlon, Maria T. Bourlon, Luca Galli, Enrique Grande, Se Hoon Park, Bohuslav Melichar, Timothy J. Schieber, Maria José Juan-Fita, Yüksel Ürün, Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Ugo De Giorgi, Jakub Kucharz, Esther Pérez Calabuig, Vincenza Conteduca, Tarek Taha, Tarek Taha, Pasquale Rescigno, Hussam Abu-Sini, Gian Paolo Spinelli, Ray Manneh Kopp, Alessia Salfi, Dipen Bhuva, Paola Valdez-Sandoval, Sofia Mendez-Bribiesca, Ondrej Fiala, Ondrej Fiala, Sebastiano Buti, Sebastiano Buti, Fernando Sabino Marques Monteiro, Fernando Sabino Marques Monteiro, Aristotelis Bamias, Marwan Ghosn, Francesco Massari, Francesco Massari, Jawaher Ansari, Matteo Santoni
Published in Frontiers in Oncology (2025-07-01)Get full text
Article -
12
Genomic Landscape in Prostate Cancer in a Latin American Population by Martín Angel, Berenice Freile, Andres Rodriguez, Federico Cayol, Ray Manneh Kopp, Patricia Rioja, Tomas Soule, Federico Losco, Laura Bernal Vaca, Jose Mauricio Penaloza, Maycos Leandro Zapata Muñoz, Silvia Patricia Neciosup, Roger Rodrigo Sanchez, Carolina Passarella, Elvio Guerreño, Diego Farelluk, Ernesto Maturana Leiva, Martin Zarba, Maria Teresa Bourlon, Mauricio Mora Pineda, Juan Pablo Sade
Published in JCO Global Oncology (2024-09-01)Get full text
Article -
13
Real‐Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON‐2 Retrospective Experience by Mimma Rizzo, Franco Morelli, Yüksel Ürün, Sebastiano Buti, Se Hoon Park, Maria T. Bourlon, Enrique Grande, Francesco Massari, Johannes Landmesser, Alexandr Poprach, Hideki Takeshita, Giandomenico Roviello, Zin W. Myint, Lazar Popovic, Andrey Soares, Halima Abahssain, Patrizia Giannatempo, Javier Molina‐Cerrillo, Lorena Incorvaia, Samer Salah, Annalisa Zeppellini, Fernando Sabino Marques Monteiro, Camillo Porta, Shilpa Gupta, Matteo Santoni
Published in Cancer Medicine (2025-02-01)Get full text
Article -
14
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy:... by Mimma Rizzo, Andrey Soares, Shilpa Gupta, Fabio Calabrò, Hideki Takeshita, Maria Teresa Bourlon, Se Hoon Park, Patrizia Giannatempo, Zin War Myint, Thomas Büttner, Enrique Grande, Ondrej Fiala, Daniele Santini, Aristotelis Bamias, Roubini Zakopoulou, Sebastiano Buti, Ravindran Kanesvaran, Pasquale Rescigno, Javier Molina-Cerrillo, Ilana Epstein, Fernando Sabino Marques Monteiro, Francesco Massari, Camillo Porta, Joaquin Bellmunt, Matteo Santoni
Published in JCO Global Oncology (2025-07-01)Get full text
Article -
15
Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma by Maria T. Bourlon, Yuly A. Remolina-Bonilla, Aldo A. Acosta-Medina, Bruno I. Saldivar-Oviedo, Antonio Perez-Silva, Nayeli Martinez-Ibarra, Francisco Javier Castro-Alonso, Ana E. Martín-Aguilar, Samuel Rivera-Rivera, Fernando Mota-Rivero, Perla Pérez-Pérez, María G. Díaz-Alvarado, José M. Ruiz-Morales, Saúl Campos-Gómez, Bertha Alejandra Martinez-Cannon, Elaine T. Lam, Nora Sobrevilla-Moreno
Published in Frontiers in Oncology (2023-11-01)Get full text
Article -
16
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study by Camillo Porta, Francesco Massari, Tarek Taha, Enrique Grande, Maria T. Bourlon, Ravindran Kanesvaran, Umberto Basso, Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Zin W. Myint, Giuseppe Fornarini, Thomas Buttner, Se Hoon Park, Yüksel Ürün, Ugo De Giorgi, Renate Pichler, Pasquale Rescigno, Tomas Buchler, Hana Studentova, Bohuslav Melichar, Jawaher Ansari, Veronica Mollica, Jakub Kucharz, Mimma Rizzo, Alessandro Rizzo, Ray Manneh Kopp, Sebastiano Buti, Fernando Sabino Marques Monteiro, Andrey Soares, Aristotelis Bamias, Matteo Santoni
Published in Cancer Immunology, Immunotherapy (2025-05-01)Get full text
Article -
17
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1) by Matteo Santoni, Giandomenico Roviello, Enrique Grande, Ugo De Giorgi, Ondrej Fiala, Emmanuel Seront, Javier Molina-Cerrillo, Renate Pichler, Zin W. Myint, Jakub Kucharz, Ravindran Kanesvaran, Thomas Büttner, Martin Pichler, Umberto Basso, Jindrich Kopecky, Maria T. Bourlon, Linda Cerbone, Tomas Buchler, Alvaro Pinto, Alfonso Gómez de Liaño, Caterina Gianni, Anca Zgura, Pasquale Rescigno, Jawaher Ansari, Orazio Caffo, Zsófia Küronya, Maria Giuseppa Vitale, Dipen Bhuva, Martina Catalano, Nuno Vau, Ray Manneh Kopp, Sebastiano Buti, Aristotelis Bamias, Camillo Porta, Kaisa Sunela, Francesco Massari
Published in Cancer Immunology, Immunotherapy (2025-05-01)Get full text
Article -
18
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors—Data From the ARON-1 Study by Francesco Massari, Matteo Rosellini, Bohuslav Melichar, Enrique Grande, Maria T. Bourlon, Haoran Li, Ondřej Fiala, Se Hoon Park, Maria José Juan Fita, Tarek Taha, Javier Molina-Cerrillo, Daniele Santini, Alfonso Gómez de Liañ, Thomas Büttner, Sarah Scagliarini, Ray Manneh Kopp, Annalisa Zeppellini, Marwan Ghosn, Vincenza Conteduca, Hatice Bölek, Alessandro Rizzo, Jawaher Ansari, Veronica Mollica, Anca Zgura, Alessandra Filosa, Ahmet Yildirim, Umut Akova, Fernando Sabino Marques Monteiro, Sebastiano Buti, Andrey Soares, Mehmet Asim Bilen, Yüksel Ürün, Matteo Santoni
Published in JCO Global Oncology (2025-10-01)Get full text
Article